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Clostridium difficile infections (CDI) are a growing concern in North America, because of their increasing incidence and sever-
ity. Using integrated approaches, we correlated pathogen genotypes and host clinical characteristics for 46 C. difficile infections
in a tertiary care medical center during a 6-month interval from January to June 2010. Multilocus sequence typing (MLST) dem-
onstrated 21 known and 2 novel sequence types (STs), suggesting that the institution’s C. difficile strains are genetically diverse.
ST-1 (which corresponds to pulsed-field gel electrophoresis strain type NAP1/ribotype 027) was the most prevalent (32.6%);
43.5% of the isolates were binary toxin gene positive, of which 75% were ST-1. All strains were ciprofloxacin resistant and metro-
nidazole susceptible, and 8.3% and 13.0% of the isolates were resistant to clindamycin and tetracycline, respectively. The corre-
sponding resistance loci, including potential novel mutations, were identified from the whole-genome sequencing (WGS) of the
resistant strains. Core genome single nucleotide polymorphisms (SNPs) determining the phylogenetic relatedness of the 46
strains recapitulated MLST types and provided greater interstrain differentiation. The disease severity was greatest in patients
infected with ST-1 and/or binary gene-positive strains, but genome-wide SNP analysis failed to provide additional associations
with CDI severity within the same STs. We conclude that MLST and core genome SNP typing result in the same phylogenetic
grouping of the 46 C. difficile strains collected in a single hospital. WGS also has the capacity to differentiate those strains within
STs and allows the comparison of strains at the individual gene level and at the whole-genome level.
Clostridium difficile infections (CDI) are the most common in-fectious antibiotic-associated gastrointestinal disorders. C.
difficile colonization of the intestine results in a range of clinical
states, ranging from asymptomatic carriage to self-limited diar-
rhea to life-threatening colitis. CDI was the leading cause of gas-
troenteritis- and gastrointestinal tract infection-associated deaths
between 1999 and 2007 in the United States (1). Risk factors for
CDI include antibiotic exposures (especially fluoroquinolones
[FQ] and cephalosporins), advanced age, and the severity of the
underlying illness (2, 3, 4).
The most common C. difficile strain that has emerged in the
past decade in North America and some areas in Europe has been
classified as 027 by ribotyping, NAP1 by pulsed-field gel electro-
phoresis (PFGE), BI by restriction endonuclease analysis, and
ST-1 bymultilocus sequence typing (MLST). ST-1 strains account
for half of the sporadic hospital-associated CDI in some settings
(5). Some studies have reported that ST-1 strains elaborate C.
difficile toxins (TCDs) at high concentrations; its purported hy-
pervirulence is plausibly related to this trait. This strain has single
and 18-bp deletions of tcdC, a negative regulator of tcdA and tcdB.
These mutations cause premature stops, and this truncation is
believed to cause toxin overproduction (6, 7). However, this as-
sumption was challenged by recent studies showing no significant
difference in toxin production between hypervirulent and nonhy-
pervirulent C. difficile strains, and no association of the tcdC ge-
notype and toxin production (8, 9).
C. difficile strains containing cdtA and cdtB binary toxin genes
are associated with greater mortality in their hosts than strains in
which these genes are absent (10). However, it is not clear if the
binary toxin genes increase the virulence of ST-1 or if they are
simply epidemiologic markers of C. difficile strains with increased
virulence (i.e., guilt by association). It is also notable that other
ribotypes with binary toxin, such as 078 (ST-11), can also cause
severe CDI, especially in young adults. These C. difficile ribotype
078 strains were highly related to animals and food-borne C. dif-
ficile strains (11). It is concerning that 078 strains have increased in
prevalence from 3% (2008) to 13% (2011) (1). CDI caused by
both 027/ST-1 and 078/ST-11 are associatedwith an increased risk
of death (12).
Our understanding of the pathogenesis of C. difficile is based
largely on studies in outbreak strains. While the epidemiology of
CDI is changing, analysis of C. difficile, especially the strains caus-
ing severe CDI, in a nonoutbreak setting might shed light on the
mechanism of the pathogenicity of sporadic C. difficile and possi-
bly produce more generalizable data. The objective of this study,
therefore, was to characterize the phenotypes and genotypes of 46
nonoutbreak C. difficile isolates from a large academic medical
center using conventional microbiological analyses and whole-
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genome sequencing and to investigate the associations between
strain phenotypes and genotypes and clinical outcomes.
MATERIALS AND METHODS
CDI severity, bacterial strains, and ribotyping and binary toxin charac-
terization. This study was approved by the Washington University Hu-
man Research Protection Office. All subjects were prospectively inter-
viewed and examined as part of a C. difficile assay comparison evaluation
(13). The presence of clinically significant diarrhea and the severity of CDI
were determined. Patients without clinically significant diarrhea or those
who were colonized with a nontoxigenic strain of C. difficile were not
classified as having CDI. Severe CDI was defined according to the clinical
practice guidelines for CDI in adults (14): subjects with a white blood cell
count of 15,000 cells/mm3 and/or serum creatinine of 1.5 times the
premorbid level at the time of CDI diagnosis. Specimens were collected,
and C. difficile strains were isolated and characterized as part of a C. diffi-
cile laboratory method study (13). Ribotyping (15) and detection of the
binary toxin genes from the isolates were performed by PCR as previously
described (16, 17).
Antibiotic susceptibility testing. C. difficile strains were tested for
antibiotic susceptibility using a gradient diffusion method according to
the manufacturer’s recommendations. Isolates of C. difficile were grown
in an anaerobic environment on prereduced sheep blood agar (BBL; BD,
Sparks, MD). A bacterial suspension was prepared in 0.9% saline to a 1
McFarland standard and then applied as a lawn of growth to Brucella agar
with hemin and vitamin K (Hardy Diagnostics, Santa Maria, CA). Etest
strips for metronidazole, clindamycin, moxifloxacin, ciprofloxacin, and
tetracycline (bioMérieux) were applied to the agar and incubated with
quality control strains according to the manufacturer’s recommenda-
tions. The resultingMIC values were interpreted according to the Clinical
and Laboratory Standards Institute guidelines (18).
Whole-genome sequencing and analysis. Genomic DNA was ex-
tracted from the 46 isolates by a BiOstic bacteremia DNA isolation kit
(MO BIO Laboratories). A genome paired-end library was constructed
with average insert lengths from 150 to 200 bp, following the Illumina
library construction protocol. The libraries were sequenced at an Illumina
2  100 bp platform. The genome assembly was performed by Velvet
(version 1.1.04-64) (19). All assemblies were subjected to host contami-
nation screening and met the criterion for draft genomes used in the
Human Microbiome Project (20). Gene annotation employed the online
RAST annotation pipeline with manual inspection (http://www.nmpdr
.org/FIG/wiki/view.cgi/FIG/RapidAnnotationServer). The open reading
frames (ORFs) were at least 300 bp long. Core gene sets were determined
by pan-genome analysis pipeline (PGAP) with default parameters using
all of the 46 C. difficile strains and reference strain 630 (21). The contigs
from the draft genomes were aligned to the C. difficile MLST database
(http://pubmlst.org/cdifficile/) to determining the sequence type (ST) us-
ing Mummer (22). The mutations from the novel ST types, regulatory
genes in the pathogenicity locus (PaLoc), binary genes, and resistance
genes were verified by manual inspection of the read alignment to refer-
ence alleles. Targeted PCR was performed to close the gaps in specific
genes such as tcdE that were not fully covered in a subset of isolates.
Single nucleotide polymorphisms (SNPs) were identified with the
SNP detection pipeline developed at theWashington University Genome
Institute (TGI) by aligning the reads to the C. difficile reference strain 630
using BWA aligner (version 0.5.9) and SAMtools (version 0.1.12). SNP
calling was performed as previously described but with increased strin-
gency (23) as follows: (i) the coverage of a SNP is at least 10 reads and
(ii) the number of reads supporting a SNP calling/the number of reads not
supporting a SNP calling is  10 (3)  12 bp between two SNP sites. A
phylogenetic tree based on the SNPs from the core gene sets was con-
structed using the neighbor-joining algorithms in Phylip (http:
//evolution.genetics.washington.edu/phylip.html).
Statistical analysis. Fisher’s exact test or the chi-square test was used
to assess whether ST-1 and the presence of binary genes in C. difficile
isolates are associated with CDI severity. P values0.05 were considered
statistically significant.
RESULTS
Isolate characterization. The 46C. difficile isolates represented 23
STs and 20 ribotypes. ST-1 (which corresponds to NAP1/027)
accounted for 32.6% of the isolates. Other STs with at least two
representatives in the collection were STs 2, 6, and 8 (Table 1).
Three strains were not assignable to any STs in the current MLST
database. One was a new allele profile (adk 3, atpA 7, dxr 14, glyA
8, recA 6, sodA 25, tpi 10), and the other two had an identical SNP
at nucleotide position 198 in sodA. The correlation of ribotypes
and STs was observed: ST-1 corresponded with ribotypes 027 and
WU42, ST-2 with ribotypes 001/VPI/77/87 and 014/020, ST-6
with ribotype 005, and ST-8 with ribotypes WU22 and WU25. In
addition, ribotypes 027 and WU42 were exclusively found in iso-
lates belonging to ST-1, whereas ribotypes 001/VPI/77/87 were
found among four STs (Table 1, Fig. 1). Thus, the ribotypes and
ST types did not have a 1:1 correlation.
We next studied the toxin-related genes, including tcdA, tcdB,
and binary genes cdtA and ctdB. tcdA and tcdB genes were detected
by conventional PCR and were further validated by sequencing.
PCR results were perfectly correlated with the sequence data for
detecting tcdA and tcdB. Binary toxin genes were also detected by
PCR and successfully reconstructed from whole-genome se-
quencing. Isolates were grouped into three categories based on the
presence of the toxin genes: (i) positive for tcdA, tcdB, cdtA, and
cdtB, which comprised 43.5% (20 of 46) of the C. difficile isolates;
(ii) positive for tcdA and tcdB  and negative for cdtA and cdtB,
which comprised 50.0% of the strains (23 of 46); and (iii) neg-
ative for tcdA, tcdB, cdtA, and cdtB, which accounted for only
three isolates (Fig. 1). Of the 20 tcdA-, tcdB-, cdtA-, and cdtB-
positive strains, 15 belonged to ST-1. Other STs containing
tcdA, tcdB and binary toxin genes were ST-11, ST-41, ST-67,
and the two novel STs.
All 46 isolates were susceptible to metronidazole (MICs from
0.032 to 4 g/ml) and resistant to ciprofloxacin (MICs of 32
g/ml). The 46 strains had MICs between 2 and 32 g/ml to
moxifloxacin (overall MIC50 and MIC90 of 8 and 32 g/ml,
respectively), and 36, 8, and 2 isolates were resistant, intermediate,
or susceptible to moxifloxacin, respectively. Of the isolates, 8.3%
and 13.0% were resistant to clindamycin and tetracycline, respec-
tively. Two (from ST35 and ST48) of the 46 isolates were resistant
to all tested antibiotics except metronidazole; these two isolates
were binary toxin gene negative and one was tcdA and tcdB nega-
tive. Five isolates were resistant to at least three antibiotics, includ-
ing ciprofloxacin, tetracycline, and moxifloxacin.
Phylogenetic concordance between ST and WGS SNP typing.
WGSwas performed on an Illumina HiSeq platformwith 2 100
bp read lengths at 100 coverage on average. Read assemblies
yielded 193 53 contigs per genome. The contigs were annotated
to provide the gene calling for each isolate. The gene content
ranged from 3,612 to 4,054 ORFs per genome, indicating signifi-
cant genetic variations across C. difficile strains. ST-1 isolates had
between 3,700 and 3,768 genes, corresponding to 121 fewer genes
on average than the other ST types in this study (see Table S1 in the
supplemental material).
To determine the core genes used for phylogeny inference, we
computed the shared genes from the 46 C. difficile strains and the
C. difficile reference strain 630 (an ST-54 strain first isolated from
C. difﬁcile Whole-Genome Sequencing
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a patient with pseudomembranous colitis). The C. difficile strain
630 was chosen as the reference because its genome was well an-
notated, and it has been widely used as the reference for SNP
identification. We identified a total of 2,871 core genes across the
isolates in this study, accounting for 64.0% of their gene content.
Between 1,096 and 44,935 SNPswere identified from thewhole
genomes of these isolates, of which 60.4% to 80.5% were distrib-
uted among the core genes. The median (interquartile range
[IQR]) number of core genome SNPs was 6,926 per stain. No
strains were identical at the SNP level, and 46 SNPswere identified
between the two closest strains. The phylogenetic tree constructed
using the SNPs from core genes from the 46 strains and the C.
TABLE 1 Phenotypic and genotypic characterization of 46 C. difficile strainsa
Strain Ribotype ST
Presence () or absence





cdtB Clindamycin Tetracycline Moxifloxacin
e01 5 6   S S R 0
a02 5 6   S S R 0
b09 5 6   S S R 1
b01 27 1   R S R 1
a01 27 1   S S R 0
a08 27 1   S S R 0
b10 27 1   S S R 1
d09 27 1   S S R 1
b07 27 1   S S R 1
d02 53 103   S S R 0
d01 77 3   S S I 0
a12 78 11   S R R 1
d10 2/75 55   S S R 0
e09 001/VPI/77/87 46   S S I 0
a11 001/VPI/77/87 48   R R R 0
b04 001/VPI/77/87 7   S R R 0
c04 001/VPI/77/87 2   S S S 0
a09 106/174 36   S S R 0
a03 106/174 42   S S R 0
c12 014/020 2   S S R 0
d04 014/020 2   S S R 0
d03 014/020 2   S S R 1
d08 014/020 14   S S R 0
b08 014/020 110   S S R 0
b05 15/46 10   S S I 1
c11 WU1 53   S S I 0
d12 WU22 35   R R I 0
c03 WU22 8   S S R 0
a04 WU22 8   S S S 0
a05 WU24 NAd   S S R 1
e04 WU25 8   S S R 0
b11 WU26 41   S S I 1
b12 WU26 10   S S R 0
e07 WU40 67   S S I 0
d11 WU42 1   S I R 0
c05 WU42 1   S S R 0
c08 WU42 1   S S R 0
c10 WU42 1   S S R 0
e03 WU42 1   S S R 0
d05 WU42 1   S S R 0
c01 WU42 1   S S R 1
e08 WU42 1   S S R 1
c09 WU42 1   S S R 1
e02 WU54 54   S R I 0
d07 WU60 NAd   S S R 1
a07 WU63 NAe   S S R 0
a Organized by the ribotypes in alphabetical order.
b S, susceptible; R, resistant; I, intermediate resistant.
c 0, not severe CDI; 1, severe CDI.
d Mutation in sodA gene.
e New allele profile.
Zhou et al.
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difficile reference strain 630 demonstrated a heterogeneous ge-
netic nature of C. difficile strains in this collection (Fig. 1). Clades
1, 2, and 5 from a previous study (24) were identified. Clade 1 was
composed of several STs. The ST-11 strain from clade 5 was most
distant from the rest of lineages with 36,039 SNPs compared to the
reference stain 630. The number of SNPs identified among the
ST-11 strains was 3.3-fold higher than those of the other STs on
average. Clade 2 was dominated by the ST-1/NAP1 strains. Two
novel ST strains were genetically most similar to the ST-1 strains,
and the third (from a nontoxigenic isolate) was distantly related to
all other strains. The cluster of the SNPs from the core gene sets
recapitulated the ST phylogeny, indicating the correspondence of
the ST type with WGS (25).
WGS can offer an improved resolution compared to MLST
characterization of isolates. For example, 99 to 656 SNP differ-
ences were detected within ST-1 strains, representing 1.3% to
4.4% of the differences in core gene sets. Within STs 6, 8, and 10,
we identified 26 to 112 SNPs in the core genes, while 1,016 SNPs
were detected for ST-2. The numbers of SNPs between ST types
ranged from 1,568 to 44,204. However, the number of strains
within a single ST type can change the degree of divergence within
a ST type and may affect the pattern we observed here.
Genetic heterogeneity of toxin-related and antibiotic resis-
tance genes. Contigs were mapped to the six genes spanning
across the PaLoc, two binary toxin genes, and resistance genes to
determine the genetic variation of these regions.
Compared to theC.difficile reference strain630, 3 strains lacked
tcdA, tcdB, tcdC, tcdE, and tcdR genes and CD630_06620 (coding
for a hypothetical protein). All PaLoc genes were present in the
remaining 43 strains. A phylogenetic tree constructed from SNPs
across the PaLoc revealed that diversity at this locus recapitulated
ST typing, except for the PaLoc associated with ST-2, which ap-
peared to bemixedwith other STs (see Fig. S1 in the supplemental
material). tcdA, tcdB, and tcdC genes had the greatest degrees of
conservation within the same ST and high variation between STs
as indicated in the circular plot (see Fig. S2 in the supplemental
material). Other genes, such as tcdR and tcdE, were conserved even
between STs, indicating different evolutionary changes in the
PaLoc. The tcdC genes in these isolates were 92.7% to 100% iden-
tical to those in reference strain 630. Sequence alignment of the 43
tcdC genes demonstrated 12 tcdC variants. Based on the deletion
pattern, we categorized the tcdC gene variants into 5 groups: (i) a
single base pair deletion at nucleotide position 117 and an 18-bp
deletion at nucleotide positions 330 to 347, which included all of
the ST-1 strains; (ii) a single base pair deletion at nucleotide posi-
tion 117 and no accompanying 18-bp deletion, which included
only the ST-41 strain; (iii) a single base pair deletion at 117 bp, an
insertion of T at 213 bp, and an 18-bp deletion, which included the
two novel ST strains and has not been previously reported; (iv) a
39-bp deletion at nucleotide position 333, which included the
ST-11 strain; and (v) single mutations without deletions, which
occurred among heterogeneous STs.
Because binary toxin genes are not present in the C. difficile
reference strain 630, the gene variation was determined by align-
ing the contigs to the binary genes in C. difficile strain CD196,
which is an epidemic ST-1 strain harboring both type of toxin
genes (26). In 15 of 21 strains, the sequences of cdtA and cdtBwere
identical to those of the CD196 strains. A transition fromT to C at
FIG 1 Phylogenetic tree of the 46C. difficile strains based on the genome-wide SNPs. The neighbor-joining phylogenetic tree was constructed based on the SNPs
from the core gene sets. C. difficile strain 630 is used as the reference strain for SNP calling. The STs and ribotypes are appended after the strain labels. The tree
is annotated by the presence of the tcdA and tcdB genes (green), binary genes (red), and disease severity (blue) at the right side of the dendrogram. The white
circles represent the absence of the toxin genes or nonsevere CDI.
C. difﬁcile Whole-Genome Sequencing
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nucleotide position 813 of the cdtA gene was discovered in the
remaining six strains containing binary toxin genes. Two ST-11
strains exhibited significant polymorphisms (21 SNPs) in com-
parison to those for CD196 in the 1,391-bp cdtA gene. Similarly,
the relation of the cdtB gene in ST-11 strainswas distant compared
to those of other STs as indicated by 49 SNPs in this 2,630-bp
region (see Table S2 in the supplemental material).
Fluoroquinolone (FQ) resistance is typically attributed to mu-
tations in gyrA and gyrB, encoding DNA gyrase subunits. Among
the 46 ciprofloxacin-resistant strains, 17 (36.9%) had a mutation
at nucleotide position 82 (substitution T¡I), as in a prototype
FQ-resistant strainR20291 (ST-1). Thismutationwas common to
all study ST-1 strains and to one ST-54 and one ST-55 strain. This
substitution at position 82 in gyrA is the cause of FQ resistance in
most European strains (27). We also identified eight other non-
synonymous mutations in gyrA from other ST strains, and these
mutations tended to be conserved in the same clades. In some
cases, these mutations are also ST specific. gyrBwas intact in most
(64.6%) strains. The precise contributions to ciprofloxacin resis-
tance at additional mutations (see Table S2 in the supplemental
material) are not yet known, but the gyrA and gyrB genes from two
moxifloxacin-susceptible strains were identical to these loci in
some of the moxifloxacin- and ciprofloxacin-resistant strains.
tetM and ermB are the genetic determinants of resistance to
tetracycline and clindamycin, respectively. Multiple polymor-
phisms were observed in tetM genes compared to those in the
reference strain 630. tetM genes displayed different degrees of het-
erogeneity between STs but were conserved within STs. Com-
pared to the rest of the STs, in the ST-11 strains tetM contained an
additional amino acid substitution at position 490 (M¡T). We
did not detect any other tet genes in the tetracycline-resistant
strains. Three strains were resistant to clindamycin. The ermB
gene of one strain (ST48) was 100% identical to the reference
strain 630. The other two strains were from ST-1 and ST-35, shar-
ing four nonsynonymous mutations at 454 (K¡Q), 511 (A¡V),
649 (Y¡H), and 664 (D¡N).
No link between SNPs and disease severity within ST-1. Se-
vere CDI accounted for 30.4% (14 of 46) of the CDI cases. The
strains associated with severe CDI were from 7 different STs with
ST-1 being predominant (46.7%). ST-6, ST-41, ST-11, ST-2, a
novel ST with a mutation in the sodA gene, and ST-10 accounted
for the remaining severe CDI cases (Fig. 1). ST-1 strains were not
significantly different in their association with severe CDI com-
pared to that of non-ST-1 strains (	2 
 1.2, df 
 1, P 
 0.28).
Among ST-1 strains, regulatory PaLoc genes (i.e., tcdC, tcdR, and
tcdE) were identical in the seven and eight isolates from patients
with severe and nonsevere CDI, respectively. Because of the highly
repeated sequences in tcdA and tcdB, full ORFs could not be con-
structed with accuracy. Thus, we compared the SNPs identified in
those two genes between ST-1 strains causing severe CDI and
nonsevere CDI. Themajority of the SNPs (88.5%)were shared for
all ST-1 strains independent of disease severity in the patients
fromwhom theywere isolated. The rest of the SNPswere shared in
either all ST-1 strains causing severe CDI/nonsevere CDI or a
proportion of the ST-1 strains causing nonsevere CDI/severe CDI.
Thus, genetic heterogeneity of the PaLoc did not distinguish dis-
ease severity within ST-1 strains (see Fig. S1 in the supplemental
material). Similarly, SNPs within the PaLoc between non-ST-1
strains (ST-6 and ST-10) failed to identify associations with CDI
severity, indicating no strong role for the genetic composition of
pathogenic loci and disease phenotype.
Interestingly, 11 of 14 (78.6%) strains causing severe CDI were
binary gene positive. Eleven of 20 (55%) binary toxin gene-posi-
tive strains were recovered from patients with severe CDI. The
chi-square test showed that binary toxin gene-positive strains
were significantly associated with severe CDI compared to binary
toxin gene-negative strains (Fisher’s exact test, P
 0.003). Thus,
the presence of binary genes might be a marker for strains that
cause severe CDI, but the current genetic data do not support the
role of binary genes in causing severe disease, as within the STs,
binary gene sequences were identical in strains causing severe CDI
and nonsevere CDI.
Whole-genome-wide SNP analysis showed that 92.3% and
92.7% of the SNPs were conserved within all of the ST-1 strains
causing severe CDI and nonsevere CDI, respectively. However, no
single SNPdistinguished the ST-1 strains causing severe CDI from
those causing nonsevere CDI.
DISCUSSION
Using integrated approaches, we delineated the phenotypes and
genotypes of C. difficile strains causing CDI from a single institu-
tion over a 6-month interval in 2010. Our data most notably in-
dicate that ST-1 strains remain predominant in nonoutbreak set-
tings, comparable to a statewide strain collection (548 strains)
conducted from 2006 to 2009 (5). The vast majority of the strains
were tcdA- and tcdB positive, and no tcdB-positive and tcdA-
negative strains were detected in our data. This is likely in line
with the low prevalence (2%) of this type of stain in the
United States, despite the high prevalence rates in Japan, Israel,
and Argentina (28).
Our data suggest that MLST and ribotyping are robust ap-
proaches for identifying phylogenic relationships in C. difficile
strains (25, 29), but the most precise resolution requires WGS.
WGS allows single nucleotide-level resolution for strain compar-
isons, thus serving as a powerful tool for outbreak investigations
and clarifying institutional versus community acquisition. As
demonstrated by outbreaks ofEscherichia coliO104:H4 in Europe,
the resolution of single nucleotide differences usingWGS data led
to the distinction of lineages from German and French isolates,
which standard tests failed to distinguish (30). Along the same
line, whole-genome sequencing of methicillin-resistant Staphylo-
coccus aureus (MRSA) in a special care nursery unit successfully
tracked the transmission within the unit (31). Recent studies have
proved the feasibility of using WGS to track C. difficile transmis-
sion (32). Importantly, more efforts are needed to conduct pro-
spective epidemiologic studies since the current studies are retro-
spective in response to a perceived outbreak, and, thus, early shifts
in local epidemiologymay not be detected (5).With the dropping
of sequencing cost and establishment of streamlined analysis pipe-
line, WGS is becoming an advantageous approach in real-time
pathogen surveillance and outbreak detection (33). Close surveil-
lance and the prospective epidemiology of the C. difficile strains,
especially those associated with severe CDI such as ST-1, ST-11,
and ST-6, might prevent future C. difficile outbreaks.
In addition, the antibiotic resistance genes identified from
WGS data matched well with the antibiotic susceptibility testing,
providing another application for WGS data in clinical settings.
However, correlation of antibiotic resistance by WGS relies on a
database of well-curated resistance genes. With the potential an-
Zhou et al.
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timicrobial resistance suggested by novel mutations identified
from WGS, phenotypic testing and genetic engineering are still
indispensable for validating the potential resistance from the
novel mutations identified from WGS. The novel mutations in
gyrA and gyrB from non-ST-1 strains revealed diverse genetic
compositions in conferring potential resistance. The mutations
require further verification to determine their role in fluoroquin-
olone resistance. The virulence genes reconstructed from WGS
reads were consistent with the toxin gene testing in the clinic,
demonstrating the versatile potentials of WGS in the clinic.
Interestingly, the phylogenetic topology of C. difficile is re-
flected in the PaLoc. Specifically, tcdC exhibited identical muta-
tions across all of the ST-1 strains, as indicated by 1- and 18-bp
deletions. Along the same line, two binary toxin genes, fluoro-
quinolone resistance genes (especially gyrA), also had identical
sequences in all of the ST-1 strains studied and differed from those
found in other STs. These findings suggest coevolution of the
MLST genes with toxin genes and gyrA.
Although the clonal nature of the C. difficile strains might pro-
vide genetic insights into pathogenicity and antibiotic resistance,
it did not shed light on the likelihood of causing severe disease.
Previous reports suggested a poor correlation between the pres-
ence of tcdC or binary genes with clinical outcomes in nonepi-
demic settings (34, 35). These studies were based on comparisons
of NAP1 strains in different severity groups without a genetic
comparison, or the genetic comparison was limited to tcdC and
binary toxin genes. In our study, we found that the presence of
binary genes in C. difficile significantly increased the risk of severe
CDI, but we could not attribute such increased risk to binary gene
sequence differences in the strains that caused severe CDI and
nonsevere CDI. Moreover, among the 40,000 SNPs throughout
these strains, no single nucleotide variation correlatedwith disease
severity. However, larger sample sizes and future multicenter
studies are needed to validate these findings. Disease presentation
and outcome are determined by multiple aspects of the host-
pathogen interaction, including toxin production, intestinal mi-
crobial ecology, host immune response, and timing and selection
of treatment. The lack of association between C. difficile genetics
and disease severity suggests that the bacterial genome itself only
partly contributes to disease severity. Future RNA sequence anal-
ysis might provide more insight into the C. difficile virulence at a
bacterial gene expression level. Also, investigation of the role of
gut microbiota in CID severity will add an ecological perspective
for understanding the disease, especially in the antibiotic-dis-
turbed ecological niche that predominates in patients with CDI.
Although this study demonstrated the potential for application
of WGS in clinical diagnosis and linked the genotype, phenotype,
and clinical outcome of a collection ofC. difficile strains, themajor
limitations of the study were small sample size and a single-center
cohort. Future work with a larger sample size will allow a more
complete picture of C. difficile epidemiology and confirm our
findings of genotypic and clinical data. Additional evaluations of a
regional or national C. difficile network will provide collective re-
sources and both facilitate epidemiological surveillance and in-
form genetic determinants linked to pathogenesis and specific-
disease phenotypes in C. difficile.
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